Evidence map›Paper›PMID 29996823›Full record

ArticleBMC medical ethics2018

Predictors of consent to cell line creation and immortalisation in a South African schizophrenia genomics study.

Megan M Campbell, Jantina de Vries, Sibonile G Mqulwana, Michael M Mndini, Odwa A Ntola, Deborah Jonker, Megan Malan, Adele Pretorius, Zukiswa Zingela, Stephanus Van Wyk and 2 more

Abstract read
In one paragraph

Article in BMC medical ethics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Megan M CampbellDepartment of Psychiatry and Mental Health, University of Cape Town, J-Block, Groote Schuur Hospital, Observatory, Cape Town, South Africa. mm.campbell@uct.ac.za.ORCID 0000-0001-9576-8562
Jantina de VriesDepartment of Medicine, University of Cape Town, Groote Schuur Hospital, Observatory, Cape Town, 8000, South Africa.
Sibonile G MqulwanaDepartment of Psychiatry and Mental Health, University of Cape Town, J-Block, Groote Schuur Hospital, Observatory, Cape Town, South Africa.
Michael M MndiniDepartment of Psychiatry and Mental Health, University of Cape Town, J-Block, Groote Schuur Hospital, Observatory, Cape Town, South Africa.
Odwa A NtolaDepartment of Psychiatry and Mental Health, University of Cape Town, J-Block, Groote Schuur Hospital, Observatory, Cape Town, South Africa.
Deborah JonkerDepartment of Psychiatry and Mental Health, University of Cape Town, J-Block, Groote Schuur Hospital, Observatory, Cape Town, South Africa.
Megan MalanDepartment of Psychiatry and Mental Health, University of Cape Town, J-Block, Groote Schuur Hospital, Observatory, Cape Town, South Africa.
Adele PretoriusDepartment of Psychiatry and Mental Health, University of Cape Town, J-Block, Groote Schuur Hospital, Observatory, Cape Town, South Africa.
Zukiswa ZingelaDepartment of Psychiatry and Behavioural Sciences, Walter Sisulu University, Mthatha, South Africa.
Stephanus Van WykDepartment of Psychiatry and Behavioural Sciences, Walter Sisulu University, Mthatha, South Africa.
Dan J SteinDepartment of Psychiatry and Mental Health, University of Cape Town, J-Block, Groote Schuur Hospital, Observatory, Cape Town, South Africa.
Ezra SusserMailman School of Public Health, Columbia University and New York State Psychiatric Institute, New York, USA.

Funding

3/3 GENOMICS OF SCHIZOPHRENIA IN THE SOUTH AFRICAN XHOSAU01MH096754 · NIMH · UNIVERSITY OF CAPE TOWN · PI STEIN, DAN JOSEPH · 2013 to 2017
$3.2M
1/3 - Genomics of Schizophrenia in the South Africa XhosaU01MH096756 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SUSSER, EZRA S. · 2013 to 2017
$1.8M
NIMH NIH HHS U01 MH096754NIMH NIH HHS U01 MH096756
6 · The paper itself

Abstract

backgroundCell line immortalisation is a growing component of African genomics research and biobanking. However, little is known about the factors influencing consent to cell line creation and immortalisation in African research settings. We contribute to addressing this gap by exploring three questions in a sample of Xhosa participants recruited for a South African psychiatric genomics study: First, what proportion of participants consented to cell line storage? Second, what were predictors of this consent? Third, what questions were raised by participants during this consent process?

methods760 Xhose people with schizophrenia and 760 controls were matched to sex, age, level of education and recruitment region. We used descriptive statistics to determine the proportion of participants who consented to cell line creation and immortalization. Logistic regression methods were used to examine the predictors of consent. Reflections from study recruiters were elicited and discussed to identify key questions raised by participants about consent.

resultsApproximately 40% of participants consented to cell line storage. The recruiter who sought consent was a strong predictor of participant's consent. Participants recruited from the South African Eastern Cape (as opposed to the Western Cape), and older participants (aged between 40 and 59 years), were more likely to consent; both these groups were more likely to hold traditional Xhosa values. Neither illness (schizophrenia vs control) nor education (primary vs secondary school) were significant predictors of consent. Key questions raised by participants included two broad themes: clarification of what cell immortalisation means, and issues around individual and community benefit.

conclusionsThese findings provide guidance on the proportion of participants likely to consent to cell line immortalisation in genomics research in Africa, and reinforce the important and influential role that study recruiters play during seeking of this consent. Our results reinforce the cultural and contextual factors underpinning consent choices, particularly around sharing and reciprocity. Finally, these results provide support for the growing literature challenging the stigmatizing perception that people with severe mental illness are overly vulnerable as a target group for heath research and specifically genomics studies.

Indexed as

Informed ConsentAdultBiological Specimen BanksBiomedical ResearchCase-Control StudiesCell LineEthnicityFemaleGenomicsHumansMaleMiddle AgedSchizophreniaSouth AfricaYoung AdultCell immortalisationConsentNeuropsychiatric genomicsPredictorsXhosa

Identifiers

PMID29996823
PMCPMC6042361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.